Semaglutide may be the better option if: Cost is the primary concern compounded semaglutide offers the most affordable path to GLP-1 therapy in 2026 You have cardiovascular disease the SELECT trial demonstrated significant reduction in major cardiovascular events with semaglutide, giving it the strongest CV evidence base of any GLP-1 medication
manual kitting becomes exponentially more error-prone
This pigmentation is observed diffusely as racial pigmentation, which can be patchy, and focally as melanotic macules and nevi
Retatrutide can continue through PCT and beyond
Other important side effects that may affect wellbeing include: Gallbladder problems (pain in the right upper abdomen, fever, jaundice) Dehydration leading to acute kidney injury, especially if vomiting or diarrhoea is severe Worsening of diabetic retinopathy in some patients, particularly with semaglutide Allergic reactions (rash, swelling, breathing difficulties) Patients should report suspected side effects to their healthcare provider and can also report them through the MHRA Yellow Card scheme